5 Grants
2004
TRIPTYCENE ANALOGS--NOVEL BIFUNCTIONAL ANTICANCER DRUGS
PERCHELLET, JEAN-PIERRE H
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA086842-05), $196,425USD, 07/01/2000 -- 06/30/2006
2003
TRIPTYCENE ANALOGS--NOVEL BIFUNCTIONAL ANTICANCER DRUGS
PERCHELLET, JEAN-PIERRE H
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA086842-04), $196,425USD, 07/01/2000 -- 06/30/2005
2002
TRIPTYCENE ANALOGS--NOVEL BIFUNCTIONAL ANTICANCER DRUGS
PERCHELLET, JEAN-PIERRE H
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA086842-03), $196,425USD, 07/01/2000 -- 06/30/2005
2001
TRIPTYCENE ANALOGS--NOVEL BIFUNCTIONAL ANTICANCER DRUGS
PERCHELLET, JEAN-PIERRE H
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA086842-02), $196,425USD, 07/01/2000 -- 06/30/2005
2000
TRIPTYCENE ANALOGS--NOVEL BIFUNCTIONAL ANTICANCER DRUGS
PERCHELLET, JEAN-PIERRE H
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA086842-01), $196,425USD, 07/01/2000 -- 06/30/2005